A new approach to finding specific dopamine D4 receptor agonists.
Hideji Morishita, Kazuhiko Shibata, Noriyuki Sakata, Satomi Kita, Takeshi Katsuragi
Index: Eur. J. Pharmacol. 516(2) , 145-50, (2005)
Full Text: HTML
Abstract
This paper describes a new approach to finding specific dopamine D4 receptor agonists based on pharmacological analysis of the contractile response to ATP in guinea pig vas deferens. A partial cDNA of the dopamine D4 receptor of the vas deferens was identified. In the vas deferens, reverse transcription-polymerase chain reaction (RT-PCR) and Western blot analysis revealed the existence of dopamine D4 receptor mRNA and D4 receptor protein, respectively. ATP (10(-7) M) induced a transient phasic contraction in the presence of prazosin (10(-7) M), an alpha1-adrenoceptor antagonist. This contraction was potentiated by dopamine receptor agonists in a concentration-dependent manner; and was antagonized by 8-Methyl-6-(4-methyl-1-piperazinyl)-11H-pyrido[2,3-b][1,4]benzodiazepine (JL-18), a dopamine D4 receptor antagonist, but not by raclopride, a dopamine D2 and D3 receptor antagonist. Assay methods utilizing contractile responses to ATP may be available for identifying novel dopamine D4 receptor agonists.
Related Compounds
Related Articles:
1995-04-01
[J. Pharmacol. Exp. Ther. 273 , 40, (1995)]
1991-05-03
[Brain Res. 547(2) , 199-207, (1991)]
1997-09-01
[J. Neurochem. 69(3) , 1246-51, (1997)]
1993-04-01
[Pharmacol. Biochem. Behav. 44(4) , 865-8, (1993)]
1992-12-01
[Exp. Cell Res. 203(2) , 491-4, (1992)]